Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 21: | Line 21: | ||
=[[BGP Company Profiles]]= | =[[BGP Company Profiles]]= | ||
=[[Publishing Companies with focus on BGP]] | =[[Publishing Companies with focus on BGP]]= | ||
=Navigation= | =Navigation= | ||
* [[Bibliography for Item 6 in BGP]]<br> | * [[Bibliography for Item 6 in BGP]]<br> | ||
* [[Biotechnology_-_Genomic_and_Proteomics]] | * [[Biotechnology_-_Genomic_and_Proteomics]] |
Latest revision as of 19:40, 22 April 2010
Introduction
The US biotechnology industry includes about 1,000 companies, with combined annual revenue close to $50 billion. Large companies include Amgen, Monsanto, Genentech, and Biogen. The biotechnology and the pharmaceutical industries overlap considerably, since many drugs are now developed using biotechnology. The industry consists of a few very large companies and many very small ones, and is fragmented by type of product. Most companies have annual sales under $50 million.
Industry overview here: Biotechnology Industry Organization
Key Industry Statistics Key Industry Figures 2008
- Industry Revenue: 85,695.4$Mil
- Revenue Growth: 12.9%
- Industry Gross Product: 58,539.2 $Mil
- Number of Establishments: 6,815 Units
- Number of Enterprises: 6,480 Units
- Employment: 341,000 Units
- Exports: 7,251$Mil
- Imports: 2,954.7$Mil
- Total Wages: *20,630.9$Mil
Source: Ibis World